Alert: Shandong takes measures to ease the shortage of resources

Recently, Shandong Province has made two important decisions to ease the pressure of resource shortages. First, the expected target of economic growth rate has been reduced to 10%. Second, new energy consumption standards have been set for all key industries in the province, making Shandong Province The main indicators of resource conservation and utilization reach the domestic or international advanced level, energy consumption per 10,000 yuan GDP is reduced by 5%, water consumption is reduced by 15%, industrial water reuse rate is increased by 10%, and real estate GDP per hectare is increased to 1.5 million yuan. Above, the comprehensive utilization of mineral resources is increased by 1% to 3%, and a group of circular economy enterprises and resource-saving parks and cities are cultivated.

Enzalutamide API And Intermediates

Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.

Our Enzalutamide API and intermedites is as following,we have all the below API and intermedites offering all year.
Enzalutamide Cas No 403-24-7;Enzalutamide Cas No 112704-79-7;

Enzalutamide Cas No 749927-69-3;Enzalutamide Cas No 915087-25-1;

Enzalutamide Cas No 143782-23-4; Enzalutamide Cas No 1289942-66-0;

Enzalutamide Cas No 1332524-01-2;Enzalutamide Cas No 915087-32-0;

Enzalutamide Cas No 915087-33-1;Enzalutamide API Cas No 915087-33-1

Enzalutamide Intermediate Cas 143782-23-4,Enzalutamide Project Cas 403-24-7,Enzalutamide API Cas 915087-33-1 Manufacturer in China

 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com